Eric D. Jacobsen

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas”.

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

Blood(2021)10.1182/blood.2021013379

N/A

4.9DataRank · unranked

180 citations

Paola Ghione, Eric D. Jacobsen, Jia Ruan, Jonathan H. Schatz, Sarah Noor +31 more

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Blood Advances(2020)10.1182/bloodadvances.2019000784

N/A

2.0DataRank · unranked

65 citations

Philippe Armand, Robert Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman +21 more

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Blood(2020)10.1182/blood.2020006464

N/A

1.9DataRank · unranked

59 citations

Jason L. Weirather, Margaretha G.M. Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen +26 more

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

New England Journal of Medicine(2017)10.1056/nejmoa1707447

N/A

1.3DataRank · unranked

5812 citations

Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson +41 more

Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.010

N/A

0.618DataRank · unranked

17 citations

Robert Redd, Erin Jeter, Jeff L. Wong, Kristin M McHugh, Carol Reynolds +21 more

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Blood(2023)10.1182/blood.2023020244

N/A

0.598DataRank · unranked

15 citations

Parastoo B. Dahi, Robert Redd, Mikaela M. McDonough, Yi‐Bin Chen, Zachariah DeFilipp +15 more

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

American Journal of Hematology(2020)10.1002/ajh.26084

N/A

0.510DataRank · unranked

29 citations

Sarah R. Walker, Lisa N. Heppler, Svitlana Tyekucheva, Erik A. Nelson, Josephine L. Klitgaard +15 more

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016006

N/A

0.385DataRank · unranked

12 citations

Yinglu Zhou, Mariia Mikhaleva, Daniel Choi, Stacey M. Fernandes, Philippe Armand +20 more

High-grade heart block associated with ibrutinib therapy

HeartRhythm Case Reports(2021)10.1016/j.hrcr.2021.03.013

N/A

0DataRank · unranked

5 citations

Benjamin L. Lampson, Eric D. Jacobsen, Edwin P. Alyea, Javid J. Moslehi, Jennifer R. Brown +1 more

Data from Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6518805.v1

N/A

0DataRank · unranked

0 citations

Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, K. Leahy +9 more